Literature DB >> 33617590

SARS-CoV-2 viral shedding characteristics and potential evidence for the priority for faecal specimen testing in diagnosis.

Chen Yuan1, Hongling Wang2, Kefeng Li1, An Tang1, Yaxin Dai1, Bing Wu2, Hui Zhang2, Jiabei Chen2, Jienan Liu1, Wenjie Wu3, Songye Gu4, Hai Wang4, Haodi Xu1, Mingyu Wu5, Menglu Yu5, Yuchao Wang1, Xinwei Yu6, Jialu He6, Shelan Liu7, Yongli Zhang6, Zhendong Tong1, Jianbo Yan6.   

Abstract

This study aimed to identify the specimen type that has high positivity and its proper sampling time for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing to promote diagnostic efficiency. All SARS-CoV-2-infected patients with a laboratory-confirmed diagnosis in Zhoushan City were followed up for viral shedding in respiratory tract specimens and faecal samples. Positivity was analysed both qualitatively and quantitatively by proper statistical approaches with strong testing power. Viral shedding in respiratory tract and faecal specimens was prolonged to 45 and 40 days after the last exposure, respectively. The overall positive rate in respiratory tract specimens was low and relatively unstable, being higher in the early-to-mid stage than in the mid-to-late stage of the disease course. Compared with respiratory tract specimens, faecal samples had a higher viral load, higher overall positive rate, and more stable positivity in different disease courses and varied symptomatic status. Faecal specimens have the potential ability to surpass respiratory tract specimens in virus detection. Testing of faecal specimens in diagnosis, especially for identifying asymptomatic carriers, is recommended. Simultaneously, testing respiratory tract specimens at the early-to-mid stage is better than testing at the mid-to-late stage of the disease course. A relatively small sample size was noted, and statistical approaches were used to address it. Information was missing for both specimen types at different stages of the disease course due to censored data. Our research extends the observed viral shedding in both specimen types and highlights the importance of faecal specimen testing in SARS-CoV-2 diagnosis. Healthcare workers, patients, and the general public may all benefit from our study findings. Disposal of sewage from hospitals and residential areas should be performed cautiously because the virus sheds in faeces and can last for a long time.

Entities:  

Year:  2021        PMID: 33617590     DOI: 10.1371/journal.pone.0247367

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  5 in total

1.  Wastewater based epidemiology as a silent sentinel of the trend of SARS-CoV-2 circulation in the community in central Argentina.

Authors:  Gisela Masachessi; Gonzalo Castro; Ariana Mariela Cachi; María de Los Ángeles Marinzalda; Matías Liendo; María Belén Pisano; Paola Sicilia; Gustavo Ibarra; Ricardo Manuel Rojas; Laura López; Gabriela Barbás; Diego Cardozo; Viviana Elisabeth Ré; Silvia Viviana Nates
Journal:  Water Res       Date:  2022-05-04       Impact factor: 13.400

2.  Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA.

Authors:  Aravind Natarajan; Alvin Han; Soumaya Zlitni; Erin F Brooks; Summer E Vance; Marlene Wolfe; Upinder Singh; Prasanna Jagannathan; Benjamin A Pinsky; Alexandria Boehm; Ami S Bhatt
Journal:  Nat Commun       Date:  2021-10-01       Impact factor: 14.919

3.  SARS-CoV-2 loads in urine, sera and stool specimens in association with clinical features of COVID-19 patients.

Authors:  Déborah Anjos; Fabiola Souza Fiaccadori; Carolina do Prado Servian; Simone Gonçalves da Fonseca; Adriana Oliveira Guilarde; Moara Alves Santa Bárbara Borges; Fernanda Craveiro Franco; Bergmann Morais Ribeiro; Menira Souza
Journal:  J Clin Virol Plus       Date:  2021-12-16

4.  Tracking Emergence and Spread of SARS-CoV-2 Omicron Variant in Large and Small Communities by Wastewater Monitoring in Alberta, Canada.

Authors:  Casey R J Hubert; Nicole Acosta; Barbara J M Waddell; Maria E Hasing; Yuanyuan Qiu; Meghan Fuzzen; Nathanael B J Harper; María A Bautista; Tiejun Gao; Chloe Papparis; Jenn Van Doorn; Kristine Du; Kevin Xiang; Leslie Chan; Laura Vivas; Puja Pradhan; Janine McCalder; Kashtin Low; Whitney E England; Darina Kuzma; John Conly; M Cathryn Ryan; Gopal Achari; Jia Hu; Jason L Cabaj; Chris Sikora; Larry Svenson; Nathan Zelyas; Mark Servos; Jon Meddings; Steve E Hrudey; Kevin Frankowski; Michael D Parkins; Xiaoli Lilly Pang; Bonita E Lee
Journal:  Emerg Infect Dis       Date:  2022-07-22       Impact factor: 16.126

5.  Replication of SARS-CoV-2 in cell lines used in public health surveillance programmes with special emphasis on biosafety.

Authors:  Shailesh D Pawar; Sadhana S Kode; Sachin S Keng; Deeksha S Tare; Ousmane M Diop; Priya Abraham; Deepa K Sharma; Lucky Sangal; Pragya D Yadav; Varsha A Potdar
Journal:  Indian J Med Res       Date:  2022-01       Impact factor: 5.274

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.